The COVID-19 active caseload remained below four lakh for the third consecutive day.
Recording over 20,000 coronavirus infections for the third consecutive day, India is set to overtake Russia's tally. According to the Johns Hopkins University, which has been compiling COVID-19 data from all over the world, India is behind Russia with 399 cases.
This is the sixth consecutive day that coronavirus infections have increased by more than 15,000. The country has seen a surge of 3,57,783 infections from June 1 till date.
India's Covid-19 tally went past the 71 lakh mark with 66,732 fresh cases, while the number of people who have recuperated has crossed 61 lakh, pushing the recovery rate to 86.36 per cent, according to the Union health ministry data updated on Monday.
The vaccine candidate -- 'Covaxin' -- is being indigenously developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
'She used to call me every day to check whether I was all right. You know how mothers are!'
Two cases of the new Omicron variant of coronavirus have been detected in Karnataka, the Union government said on Thursday while asking people not to panic but follow Covid-appropriate behaviour and get vaccinated without delay.
"Lockdown and containment (measures) have been successful in keeping it low and preventing rapid spread," ICMR Director General Balram Bhargava said, citing the sero-survey on COVID-19 spread.
The active cases have surpassed the 12-lakh mark, while the death toll increased to 1,70,179 with 904 daily new fatalities, the highest since October 18, the data updated at 8 am showed.
'We must not compromise with the standard, the quality. We don't need to be the first to launch a drug but what we need is a Made in India vaccine that the entire world can rely on'
A total of 94,612 people recovered from coronavirus in a span of 24 hours, taking the national recovery rate to 79.68 per cent, while 92,605 people tested positive for the disease during the period, taking the total COVID-19 cases to 54,00,619.
The total coronavirus cases mounted to 51,18,253, while the death toll climbed to 83,198 with the virus claiming 1,132 lives in a span of 24 hours, the data updated at 8 am showed.
The test kit has the advantage of testing 90 samples together in a single run of 2.5 hours, so that healthcare professionals can proceed quickly with necessary next steps.
The phase 3 trial findings indicate that Covaxin induces a robust antibody response with no severe vaccine-related adverse events or deaths reported among the trial participants, the authors of the study said.
Politics, bureaucracy, ineptitude, double-standards and an attempt to politicise the fight in pseudo-nationalistic terms have all hampered the fight against this deadly virus, says Vir Sanghvi.
Strict norms for arriving international passengers, especially from 'at-risk' countries, will come into effect from Tuesday midnight and authorities are stepping their vigil for effective surveillance amid mounting concerns over the emergence of the coronavirus variant Omicron.
The COVID-19 case fatality rate has further declined to 1.52 per cent.
According to government sources, the matter was discussed by the national expert group on vaccine administration for COVID-19 in its last meeting held on August 22.
A total of 40,845 cases of black fungus or mucormycosis have been reported in the country so far, of which 31,344 are rhinocerebral in nature, and the death toll from the infections stands at 3,129, Union Health Minister Harsh Vardhan said.
Their close contacts have also been put under quarantine. Comprehensive contact tracing has been initiated for co-travellers, family contacts and others. Genome sequencing on other specimens is going on, the ministry said.
The phase-three human clinical trial of indigenously developed anti-coronavirus vaccine candidate Covaxin began at the AIIMS in New Delhi on Thursday, with Dr M V Padma Srivastava, the chief of Neurosciences Centre at the premier institute, and three other volunteers receiving the first dose.
All these persons have been kept in single room isolation in designated health care facilities by respective state governments.
The number of total coronavirus cases rose to 92,22,216 in the country, while the death toll due to the disease climbed to 1,34,699 with 481 new fatalities, the ministry's data updated at 8 am showed.
The decline in the effectiveness of Covaxin, India's indigenous COVID-19 vaccine, from 77.8 per cent to 50 per cent during a Delta-driven case surge in April and May this year is neither bad nor surprising, say scientists.
The burgeoning death notices come amid apprehensions that the number of cases and casualties are being underreported for a variety of reasons.
The total recoveries have surged to 84,78,124 pushing the national recovery rate to 93.67 per cent, while the COVID-19 case fatality rate stands at 1.47 per cent.
Of the 418 deaths reported in the last 24 hours, 181 are from Maharashtra.
As Kerala reeled under a daily increase of nearly 30,000 cases of COVID-19, the deadly Nipah virus has come as another thorn in its side, prompting the state to further heighten the alertness of its health machinery to prevent an outbreak of a different infection.
Agarwal said that the current 'R0' or R naught for the coronavirus infection is somewhere between 1.5 and 4.
Family members of people who committed suicide within 30 days of being diagnosed with COVID-19 will be entitled to Rs 50,000 ex-gratia assistance as per the guidelines, the Centre told the Supreme Court on Thursday.
While the United States' share in global COVID-19 cases is 22.4 per cent, those who have recuperated there comprise 18.6 per cent of total worldwide recoveries, according to data presented by Bhushan.
An expert committee of the Central Drugs Standard Control Organisation (CDSCO) on Wednesday sought additional safety and efficacy data for COVID-19 vaccine candidates of Serum Institute and Bharat Biotech, after deliberating upon their applications seeking emergency use authorisation for the shots, official sources said.
The COVID-19 active caseload remained below 4 lakh for the second consecutive day.
The Union Health Ministry has said in response to a Right to Information application that it does not know where records related to agenda circulated in meetings of the National Expert Group on Vaccine Administration for COVID-19 are held.
'Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use authorization for its COVID-19 vaccine in India'
In its letter to Modi, the IMA said it was gratifying to note that only 0.06 per cent of people who received both the doses of vaccine "got minimal" infection by coronavirus, and "very rarely" vaccinated people had a severe lung infection.
All these people have been kept in single room isolation in designated healthcare facilities by respective state governments and their close contacts have also been put under quarantine, the ministry said.
'Even if Serum Institute and Bharat Biotech were successful in ramping up production overnight, what happens to the capacity after the demand from India is met?' asks Sanjeev Nayyar.
Thirty districts in the country, including 13 in Kerala, eight in Mizoram, four in Meghalaya, three each in Manipur and Arunachal Pradesh, two in Sikkim and one in Meghalaya are reporting a weekly positivity rate of over 10 per cent.
The govt warned the second wave of coronavirus infection in India was not yet over even though the weekly positivity rate was showing an overall declining trend.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances